Daniela Fernandes Ramos
Overview
Explore the profile of Daniela Fernandes Ramos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hadrich G, Vaz G, Bidone J, Yurgel V, Teixeira H, Goncalves Dal Bo A, et al.
Pharmaceutics
. 2022 Oct;
14(10).
PMID: 36297456
Despite a considerable number of new antibiotics under going clinical trials, treatment of intracellular pathogens still represents a major pharmaceutical challenge. The use of lipid nanocarriers provides several advantages such...
12.
Olmedo D, Martins K, Paz M, Fernandes C, da Silva Junior F, Ramos D
Rev Assoc Med Bras (1992)
. 2022 Oct;
68(9):1191-1198.
PMID: 36228250
Objective: Bronchiectasis is a chronic respiratory disease characterized by inflammation, irreversible dilation of the bronchi, and recurrent pulmonary infections, with a high morbidity and mortality rate, but is less studied...
13.
Bartolomeu Halicki P, Pereira I, Zanatta N, de Andrade V, da Silva P, Ramos D
Tuberculosis (Edinb)
. 2022 Sep;
136:102252.
PMID: 36063660
Due to several obstacles in treating tuberculosis (TB), the search for new therapeutic alternatives remains a global priority. The nitrogenous heterocyclic compounds are promising in searching for new anti-Mycobacterium tuberculosis...
14.
Reis A, Lemos Dal Pizzol J, Gattelli R, Groll A, Ramos D, Ramis I, et al.
Rev Soc Bras Med Trop
. 2022 Aug;
55:e0198.
PMID: 35976335
Background: Tuberculosis (TB) remains a serious public health problem, with approximately 10 million new cases reported annually. Knowledge about the quantitative evolution of theses and dissertations (T&Ds) examining human TB...
15.
Caprara C, da Silva Freitas L, Iglesias B, Ferreira L, Ramos D
Biofouling
. 2022 Jul;
38(6):605-613.
PMID: 35875928
In the last decade has emerged as a pathogen associated with infections in intensive care units worldwide, especially due to its ability to resist an extensive list of antibiotics. In...
16.
Ramos D, Bartolomeu Halicki P, Caprara C, Borges P, DOca C, Santos M, et al.
Chem Biodivers
. 2022 Mar;
19(5):e202100846.
PMID: 35290725
Microalgae, due to its rapid growth, low nutritional requirements, and versatility of adaptation to different environmental conditions, has aroused the biotechnological interest, synthesizing novel molecules with antioxidant, anticoagulant, anti-inflammatory, antitumor,...
17.
de Lourdes do Carmo Guimaraes Diniz J, Groll A, Unis G, Dalla-Costa E, Rossetti M, Vianna J, et al.
Tuberculosis (Edinb)
. 2021 Oct;
131:102137.
PMID: 34673379
Treatment of drug-resistant tuberculosis requires extended use of more toxic and less effective drugs and may result in retreatment cases due to failure, abandonment or disease recurrence. It is therefore...
18.
Volcao L, Bartolomeu Halicki P, Christ-Ribeiro A, Ramos D, Badiale-Furlong E, Andreazza R, et al.
J Toxicol Environ Health A
. 2021 Aug;
85(2):43-55.
PMID: 34459359
(Wint.) Honey is a plant pathogenic fungus that infects stone fruits such as peach, nectarine and plum, which are high demand cultivars found in Brazil. This pathogen may remain latent...
19.
Georg Magalhaes C, Moreira G, Ferreira M, Dos Santos L, Finger P, Ramos D, et al.
Biologicals
. 2021 Jul;
72:54-57.
PMID: 34247914
Tuberculosis (TB) is one of the top 10 causes of death in humans worldwide. The most important causative agents of TB are bacteria from the Mycobacterium tuberculosis complex (MTC), although...
20.
Bartolomeu Halicki P, Vianna J, Zanatta N, de Andrade V, de Oliveira M, Mateus M, et al.
Bioorg Med Chem Lett
. 2021 May;
42:128088.
PMID: 33964440
Although the administration of combined therapy is efficient to tuberculosis (TB) treatment caused by susceptible Mycobacterium tuberculosis strains, to overcome the multidrug resistance is still a challenge. Some studies have...